(123)I-FP-CIT SPET striatal uptake in parkinsonian patients with the alpha-synuclein (G209A) mutation A

Hell J Nucl Med. 2008 Sep-Dec;11(3):157-9.

Abstract

Autosomal dominant familial Parkinson's disease (PD) due to the alpha-synuclein (G209A) mutation shares similar clinical characteristics with sporadic PD. Pathological studies however indicate more widespread neuronal degeneration in the familial form. We performed (123)I-FP-CIT SPET (DaTSCAN) study in nine patients with familial PD carrying the alpha-synuclein (G209A) mutation and fifteen matched patients with sporadic disease. Both groups had equal radioligand reduction uptake in the striatum but the alpha-synuclein patients showed less asymmetry and increased putamen to caudate ratio. Our findings indicate that there are minor differences in DAT SPET parameters between alpha-synuclein and sporadic PD patients insufficient to provide differential diagnosis.

MeSH terms

  • Adult
  • Corpus Striatum / metabolism
  • Humans
  • Iodine Radioisotopes
  • Middle Aged
  • Mutation
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / genetics
  • Parkinson Disease / metabolism*
  • Positron-Emission Tomography
  • Radiopharmaceuticals / pharmacokinetics*
  • Tropanes / pharmacokinetics*
  • alpha-Synuclein / genetics*

Substances

  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • Tropanes
  • alpha-Synuclein
  • 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane